UY38229A - Compuestos de ciclopentano - Google Patents
Compuestos de ciclopentanoInfo
- Publication number
- UY38229A UY38229A UY0001038229A UY38229A UY38229A UY 38229 A UY38229 A UY 38229A UY 0001038229 A UY0001038229 A UY 0001038229A UY 38229 A UY38229 A UY 38229A UY 38229 A UY38229 A UY 38229A
- Authority
- UY
- Uruguay
- Prior art keywords
- compounds
- cyclopentan
- medicine
- processes
- formula
- Prior art date
Links
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical class C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 title 1
- 125000001511 cyclopentyl group Chemical class [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing alicyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2018086503 | 2018-05-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY38229A true UY38229A (es) | 2019-11-29 |
Family
ID=66542241
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY0001038229A UY38229A (es) | 2018-05-11 | 2019-05-10 | Compuestos de ciclopentano |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US11274091B2 (enExample) |
| EP (1) | EP3790870B1 (enExample) |
| JP (1) | JP7418354B2 (enExample) |
| KR (1) | KR102806779B1 (enExample) |
| CN (1) | CN112424182B (enExample) |
| AR (1) | AR115382A1 (enExample) |
| AU (1) | AU2019266525B2 (enExample) |
| BR (1) | BR112020023065A2 (enExample) |
| CA (1) | CA3099507A1 (enExample) |
| DK (1) | DK3790870T3 (enExample) |
| ES (1) | ES2944735T3 (enExample) |
| MX (1) | MX2020012065A (enExample) |
| PT (1) | PT3790870T (enExample) |
| TW (1) | TWI830733B (enExample) |
| UY (1) | UY38229A (enExample) |
| WO (1) | WO2019215268A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI830733B (zh) * | 2018-05-11 | 2024-02-01 | 中國大陸商迪哲（江蘇）醫藥有限公司 | 環戊烷化合物 |
| JP7594274B2 (ja) * | 2019-10-24 | 2024-12-04 | 国立大学法人大阪大学 | 難聴の予防および／または治療用医薬組成物 |
| WO2025008249A1 (en) | 2023-07-06 | 2025-01-09 | Basf Se | Triazole compounds for the control of invertebrate pests |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102004017930A1 (de) * | 2004-04-14 | 2005-11-03 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel |
| EP1753740A2 (en) * | 2004-05-21 | 2007-02-21 | Merck & Co., Inc. | Amino cyclopentyl heterocyclic and carbocyclic modulators of chemokine receptor activity |
| RU2481336C2 (ru) * | 2006-07-06 | 2013-05-10 | Эррэй Биофарма Инк. | Циклопента(d)пиримидины в качестве ингибиторов протеинкиназ акт |
| TW200940542A (en) * | 2008-01-09 | 2009-10-01 | Array Biopharma Inc | Pyrimidyl cyclopentanes as AKT protein kinase inhibitors |
| PL2370442T3 (pl) * | 2008-11-26 | 2013-08-30 | Pfizer | 3-Aminocyklopentanokarboksamidy jako modulatory receptora chemokiny |
| US7893099B2 (en) * | 2009-06-11 | 2011-02-22 | Hoffman-La Roche Inc. | Cyclopentane derivatives |
| EP2368876A1 (en) * | 2010-03-01 | 2011-09-28 | Sanofi | Derivatives of aminoindanes, their preparation and their application in therapeutics |
| EP3010916B1 (en) * | 2013-06-21 | 2017-09-27 | Merck Patent GmbH | 1,3-diaminocyclopentane carboxamide derivatives |
| MX2016001134A (es) * | 2013-07-29 | 2016-04-29 | Merck Patent Gmbh | Derivados 1,3-disustituidos de ciclopentano. |
| TWI830733B (zh) * | 2018-05-11 | 2024-02-01 | 中國大陸商迪哲（江蘇）醫藥有限公司 | 環戊烷化合物 |
-
2019
- 2019-05-06 TW TW108115491A patent/TWI830733B/zh active
- 2019-05-09 EP EP19724152.4A patent/EP3790870B1/en active Active
- 2019-05-09 PT PT197241524T patent/PT3790870T/pt unknown
- 2019-05-09 CN CN201980046444.XA patent/CN112424182B/zh active Active
- 2019-05-09 WO PCT/EP2019/061888 patent/WO2019215268A1/en not_active Ceased
- 2019-05-09 BR BR112020023065-0A patent/BR112020023065A2/pt active Search and Examination
- 2019-05-09 AU AU2019266525A patent/AU2019266525B2/en active Active
- 2019-05-09 JP JP2020563695A patent/JP7418354B2/ja active Active
- 2019-05-09 ES ES19724152T patent/ES2944735T3/es active Active
- 2019-05-09 MX MX2020012065A patent/MX2020012065A/es unknown
- 2019-05-09 DK DK19724152.4T patent/DK3790870T3/da active
- 2019-05-09 CA CA3099507A patent/CA3099507A1/en active Pending
- 2019-05-09 KR KR1020207035633A patent/KR102806779B1/ko active Active
- 2019-05-10 UY UY0001038229A patent/UY38229A/es not_active Application Discontinuation
- 2019-05-10 AR ARP190101251A patent/AR115382A1/es unknown
-
2020
- 2020-11-11 US US17/095,725 patent/US11274091B2/en active Active
-
2021
- 2021-12-27 US US17/562,022 patent/US12378218B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20220194922A1 (en) | 2022-06-23 |
| EP3790870B1 (en) | 2023-04-19 |
| KR20210018287A (ko) | 2021-02-17 |
| TWI830733B (zh) | 2024-02-01 |
| KR102806779B1 (ko) | 2025-05-12 |
| CN112424182A (zh) | 2021-02-26 |
| US20210070733A1 (en) | 2021-03-11 |
| MX2020012065A (es) | 2021-02-26 |
| DK3790870T3 (da) | 2023-05-08 |
| CA3099507A1 (en) | 2019-11-14 |
| JP2021523178A (ja) | 2021-09-02 |
| AR115382A1 (es) | 2021-01-13 |
| PT3790870T (pt) | 2023-05-05 |
| CN112424182B (zh) | 2023-05-23 |
| JP7418354B2 (ja) | 2024-01-19 |
| AU2019266525A1 (en) | 2020-11-26 |
| AU2019266525B2 (en) | 2024-06-13 |
| US11274091B2 (en) | 2022-03-15 |
| TW202016087A (zh) | 2020-05-01 |
| BR112020023065A2 (pt) | 2021-02-02 |
| US12378218B2 (en) | 2025-08-05 |
| WO2019215268A1 (en) | 2019-11-14 |
| ES2944735T3 (es) | 2023-06-23 |
| EP3790870A1 (en) | 2021-03-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2019002824A1 (es) | Anticuerpos anti-lag3. | |
| UY38793A (es) | Compuestos químicos | |
| CO2019002596A2 (es) | Un esteroide 19-nor-c21-n-pirazolilo c3,3-disustituido cristalino | |
| MX2019015744A (es) | Composiciones farmaceuticas. | |
| CL2018001790A1 (es) | Procesos para preparar un inhibidor de jak1 y nuevas formas de este (divisional solicitud 201602748) | |
| MX2023014120A (es) | Formulaciones de anticuerpos inhibidores de masp-2 altamente concentradas de baja viscosidad, kits, y metodos. | |
| ECSP20021132A (es) | Enantiómeros de tiazoles sustituidos compuestos antivirales | |
| DOP2019000290A (es) | Inhibidores de quinasa y usos de los mismos | |
| CU20150053A7 (es) | Inhibidores de bmi-1 de pirimidina inversa sustituida | |
| CO2019006687A2 (es) | Polimorfos | |
| UY37193A (es) | Nuevos compuestos antivíricos | |
| UY36737A (es) | 3-amino-1,5,6,7-tetrahidro-4h-indol-4-onas | |
| UY36166A (es) | Formas de sales de n—(cianometil)—4—(2—(4—morfolinofenilamino)pirimidin—4—il)benzamida, sus composiciones y su uso terapeutico | |
| CO2019006673A2 (es) | Polimorfos | |
| UY36500A (es) | Composiciones del inhibidor de la nitrificación y métodos de preparación de las mismas | |
| MX2020002123A (es) | Sales de ribociclib y formas en estado sólido de las mismas. | |
| MX2018002416A (es) | Derivados de 1,7-diaril-1,6-heptadien-3,5-diona, procedimiento para la preparación y uso de los mismos. | |
| CO2019011980A2 (es) | Formas cristalinas de (s)-afoxolaner | |
| MX2019010643A (es) | Formas y composiciones de un inhibidor de proteina cinasa 2 activada por la proteina cinasa activada por mitogeno (mk2). | |
| CL2020001618A1 (es) | Polimorfos. | |
| BR112018014355A2 (pt) | processos para a preparação de f-benzoxazinorifamicina i e para a preparação de 2-amino-5-fluorobenzeno-1,3-diol iii | |
| MX376335B (es) | Tinturas reactivas fluorescentes, proceso para su produccion y su uso. | |
| CO2018002364A2 (es) | Una novedosa forma de isoxadifeno-etilo, un proceso para su preparación y uso de la misma | |
| MX2020012065A (es) | Compuestos de ciclopentano. | |
| CO2018012110A2 (es) | Procedimiento para la preparación de cuerpos moldeados para la administración a animales |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 109 | Application deemed to be withdrawn |
Effective date: 20240522 |